129 related articles for article (PubMed ID: 26826396)
1. Circulating TGF-β1 levels are negatively correlated with sclerostin levels in early postmenopausal women.
Cheng Q; Tang W; Sheu TJ; Du Y; Gan J; Li H; Hong W; Zhu X; Xue S; Zhang X
Clin Chim Acta; 2016 Apr; 455():87-92. PubMed ID: 26826396
[TBL] [Abstract][Full Text] [Related]
2. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
Mirza FS; Padhi ID; Raisz LG; Lorenzo JA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1991-7. PubMed ID: 20156921
[TBL] [Abstract][Full Text] [Related]
3. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
[TBL] [Abstract][Full Text] [Related]
4. Determinants of serum sclerostin in healthy pre- and postmenopausal women.
Ardawi MS; Al-Kadi HA; Rouzi AA; Qari MH
J Bone Miner Res; 2011 Dec; 26(12):2812-22. PubMed ID: 21812027
[TBL] [Abstract][Full Text] [Related]
5. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
6. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
[TBL] [Abstract][Full Text] [Related]
7. Association of circulating sclerostin levels with fat mass and metabolic disease--related markers in Japanese postmenopausal women.
Urano T; Shiraki M; Ouchi Y; Inoue S
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1473-7. PubMed ID: 22639287
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
[TBL] [Abstract][Full Text] [Related]
9. Increase in circulating sclerostin at the early stage of menopausal transition in Japanese women.
Matsui S; Yasui T; Kasai K; Keyama K; Kato T; Uemura H; Kuwahara A; Matsuzaki T; Irahara M
Maturitas; 2016 Jan; 83():72-7. PubMed ID: 26508082
[TBL] [Abstract][Full Text] [Related]
10. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.
Gaudio A; Pennisi P; Bratengeier C; Torrisi V; Lindner B; Mangiafico RA; Pulvirenti I; Hawa G; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2010 May; 95(5):2248-53. PubMed ID: 20305005
[TBL] [Abstract][Full Text] [Related]
11. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
[TBL] [Abstract][Full Text] [Related]
12. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women.
Sheng Z; Tong D; Ou Y; Zhang H; Zhang Z; Li S; Zhou J; Zhang J; Liao E
Clin Endocrinol (Oxf); 2012 Jun; 76(6):797-801. PubMed ID: 22151063
[TBL] [Abstract][Full Text] [Related]
13. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
[TBL] [Abstract][Full Text] [Related]
14. Circulating sclerostin levels in relation to nutritional status, sex hormones and selected bone turnover biochemical markers levels in peri- and postmenopausal women.
Czajkowska M; Plinta R; Owczarek A; Olszanecka-Glinianowicz M; Skrzypulec-Plinta V
Ginekol Pol; 2019; 90(7):371-375. PubMed ID: 31392705
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus.
Catalano A; Pintaudi B; Morabito N; Di Vieste G; Giunta L; Bruno ML; Cucinotta D; Lasco A; Di Benedetto A
Eur J Endocrinol; 2014 Sep; 171(3):293-300. PubMed ID: 24891138
[TBL] [Abstract][Full Text] [Related]
16. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.
Anastasilakis AD; Polyzos SA; Gkiomisi A; Bisbinas I; Gerou S; Makras P
J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684
[TBL] [Abstract][Full Text] [Related]
17. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.
Mödder UI; Hoey KA; Amin S; McCready LK; Achenbach SJ; Riggs BL; Melton LJ; Khosla S
J Bone Miner Res; 2011 Feb; 26(2):373-9. PubMed ID: 20721932
[TBL] [Abstract][Full Text] [Related]
18. Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis.
Catalano A; Morabito N; Basile G; Brancatelli S; Cucinotta D; Lasco A
J Clin Endocrinol Metab; 2013 May; 98(5):1911-5. PubMed ID: 23596142
[TBL] [Abstract][Full Text] [Related]
19. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
[TBL] [Abstract][Full Text] [Related]
20. Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.
Zhou YJ; Li A; Song YL; Zhou H; Li Y; Tang YS
Chin Med Sci J; 2013 Sep; 28(3):135-9. PubMed ID: 24074614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
